Medifocus Inc. Reports Improved Clinical Efficacy For Its Phase II, Randomized Clinical Study For The Treatment Of Early Stage Breast Cancer Tumors

News — By on April 24, 2009 at 5:13 am

VANCOUVER — Medifocus Inc. announced that positive clinical results when using the Company’s proprietary focused heat treatment prior to surgery for the treatment of early stage breast cancer tumors, were presented during the Market Opening Ceremony of Medifocus at the Toronto Stock Exchange on March 25, 2009 and also at the 19th National Interdisciplinary Breast Center Conference held March 14-18, 2009 in Las Vegas, Nevada. The patient data were obtained from a multi-center, randomized clinical study to reduce cancer cells at the surgical margins, which potentially can reduce either re-excision rates or second incision rates when Medifocus’s focused heat is delivered prior to surgery. This study was conducted in the USA…

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback